Clinical Trial Update: A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase III trial of Xilonix in advanced/metastatic colorectal cancer was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Xilonix

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: TERMINATED | Results posted: 2021-06-29